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Abstract
Purpose: To evaluate histological changes in the corneal stroma in pseudophakic bullous keratopathy.
Methods: Twenty-eight patients (28 eyes) with pseudophakic bullous keratopathy underwent therapeutic penetrating
keratoplasty at Shandong Eye Institute between January 2006 and November 2011. The patients were divided into two
groups according to the duration of bullous keratopathy (,1.0 year group or .1.0 year group), and three buttons from
enucleated eyes with choroidal melanoma served as a control. In vivo confocal microscopy examination, hematoxylin–eosin,
Masson’s trichrome stain and Van Gieson staining were used for microscopic examination. The histological evaluation and
scoring of the buttons for morphological changes, including the degree of stromal scars, neovascularization and
inflammatory cells within the corneal buttons, were compared. To study the underlying mechanism, connective tissue
growth factor (CTGF) and TGF-b immunohistochemistry were performed.
Results: Confocal microscopy examination and histological evaluation and scoring of the buttons showed that compared
with the ,1.0 year group, stromal scars, neovascularization and inflammatory cells were more severe in the .1.0 year
group (P,0.05). There was an increase in CTGF- and TGF-b1-positive stromal cells in the .1.0 year group.
Conclusions: During the progression of pseudophakic bullous keratopathy, stromal scars occurred more often in the
patients that had a longer duration of disease. Cytokines such as CTGF and TGF-b1 may play a role in this pathological
process and deserve further investigation.
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Introduction
Pseudophakic bullous keratopathy has recently emerged as
a leading cause of endothelial keratoplasty (EK). EK maintains
most of the corneal structure and the integrity of the eye as a result
of a small incision, no sutures and rapid recovery; therefore, it is
increasingly becoming the preferred method for treating bullous
keratopathy [1–3]. However, not all of the patients with bullous
keratopathy can benefit from endothelium transplantation. Par-
ticularly in patients with a long duration of bullous keratopathy,
EK cannot produce good vision because of the intense corneal
stromal scars and neovascularization; thus, penetrating kerato-
plasty should be used [4–6].
During the development of pseudophakic bullous keratopathy,
there are pathological changes in the corneal stroma, such as scar
formation, the proliferation of a collagenous layer and fibrillar
material deposits. An abnormal proliferation of the posterior
collagenous layer and a significantly lower keratocyte density was
found in the posterior part of the stroma of patients with long-term
pseudophakic bullous keratopathy [7]. It has also been reported
that abnormal fibrillar materials posterior to Descemet’s mem-
brane and subepithelial fibrocellular materials disrupt the epithe-
lial basement membrane and Bowman’s layer in the corneas of
bullous keratopathy patients [8].
These studies suggested that pathological changes occurred in
the corneal stroma during pseudophakic bullous keratopathy.
However, the relationship between corneal scar severity and the
progression of bullous keratopathy is still unclear. In addition,
the underlying molecular mechanism is unknown. Recent
studies have shown that CTGF promotes corneal scar forma-
tion, and CTGF expression significantly increases during
corneal wound healing [9]. CTGF was also found to be
involved in the TGF-b1-mediated stimulation of myofibroblast
differentiation and collagen matrix contraction in the presence
of mechanical stress [10].
However, whether CTGF plays a role during scar formation in
bullous keratopathy has not been reported. This study may
provide a histological and molecular reference for the evaluation
of corneal scar formation during the progression of pseudophakic
bullous keratopathy.
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This retrospective institutionally reviewed study was approved
by the Institutional Review Board of Shandong Eye Institute and
conducted in accordance with the ethical standards of the 1964
Declaration of Helsinki. We obtained written informed consent
from all participants involved in our study. The series consisted of
28 patients (13 females and 15 males) with a clinical diagnosis of
different durations of pseudophakic bullous keratopathy at
Shandong Eye Institute between January 2005 and November
2011. All of the patients presented eye pain, corneal edema, and
an obvious low endothelium count (from less than 600 cells/mm to
none detectable).
Based on the duration of pseudophakic bullous keratopathy, the
patients were divided into two groups: the ,1.0 year group with
9 patients (4 males, mean duration of 0.560.2 years, and mean
age of 50.7614.5 years) and the .1.0 year group with 19 patients
(11 males, mean duration of 3.162.9 years, and mean age of
58.3615.1 years). Three buttons from enucleated eyes with
choroidal melanoma served as the control.
In Vivo Scanning Confocal Microscopy
Confocal microscopy images were obtained before surgery.
Informed consent was obtained from all of the patients before the
examination. After one drop of 0.5% proparacaine hydrochloride
(Alcon Laboratories, Fort Worth, Texas, USA), the central cornea
was examined with a scanning confocal microscope (Confoscan 4;
Nidek Technologies America, Greensboro, North Carolina, USA).
The center and four quadrant points within 6 mm of the central
cornea were examined. Serial images were acquired with a 403
non-applanating immersion lens that had a concave surface and
a working distance of 1.9 mm. Approximately 300 sequential
images were obtained from the endothelium to the epithelium
during a single examination.
Corneal Staining
Details regarding penetrating keratoplasty have been reported
previously [11]. All of the surgeries were performed under general
anesthesia. The corneal buttons werehalf-cut along the central line.
Serially graded ethanol baths followed by xylene were used to
dehydratethetissuesbeforetheywereimmersedinparaffinwax.The
samples were embedded in paraffin molds, sectioned at 4-mm
thickness, and mounted on glass slides. To determine whether the
centralcornealbuttonswasrepresentative,serial4-mmsectionswere
cutthroughtheentirecentralcorneaat200-mmintervals.Becausethe
slides were found to be consistent from section to section,
representative sections from the central corneal buttons were used.
Hematoxylin–eosin,Masson’strichromestainandVanGiesonstain
were used for microscopic examination and evaluation.
Histological Evaluation and the Scoring of the Buttons
The buttons were histologically evaluated and scored, including
the thickness of the stromal scars, the number of vessels in the
neovascularization and the number of inflammatory cells within
corneal buttons. The pathological changes were graded from 0 to
3 based on the severity of each characteristic. For stromal scar
thickness, a thickness of the stromal scars less than 1/3 of the
entire stroma was graded as 1, 1/3-2/3 of the entire stroma was
graded as 2, greater than 2/3 of the entire stroma was graded as 3,
and no scars was graded as 0. Six high-power fields were randomly
chosen in each slide, and the number of vessels and the number of
inflammatory cells per high-power field were counted within
corneal buttons. All of the slides were evaluated by the same
pathologist. The specimens were coded on the posterior surfaces,
and the diagnosis was unknown to the observer. The total score
and each characteristic were statistically analyzed. For each
cornea, measurements were obtained for every parameter, and the
means of the values were calculated.
Immunohistochemistry
For immunohistochemistry, 4-mm sections (repeated at least
three times for each group) were obtained from the paraffin-
embedded corneal buttons. The antigens were recovered by
microwaving for 15 min in EDTA solution. Endogenous perox-
idase activity was quenched by incubating the sections in 3%
hydrogen peroxide for 5 min. Normal goat serum was used to
block nonspecific staining. Subsequently, the sections were in-
cubated with mouse anti-TGF-b1 (Maxin, Fujian, China) or rabbit
anti-CTGF (Abcam, Hong Kong) for 60 min at 37uC, a reinfor-
cing agent (Maxim, Fujian, China) for 15 min at 37uC, and HRP
conjugated goat anti-rabbit IgG for 30 min at 37uC. Peroxidase
activity was visualized by incubating the sections in diaminoben-
zidine (DAB) solution (Maxim, Fujian, China). Negative controls
were performed in the absence of primary antibodies. Finally, the
samples were mounted and examined with a microscope (Nikon
Eclipse E800, Nikon, Tokyo, Japan).
Statistical Analysis
Significant differences among the three groups were evaluated
with the Student-Newman-Keuls one-way ANOVA using the
SPSS 13.0 software. The mean 6 standard deviation is shown,
and P-values ,0.05 were considered statistically significant.
Results
Clinical Treatment
No infection was observed after surgery, and no postoperative
complications occurred during follow-up. The best ocular vision
was significantly increased after penetrating keratoplasty, and the
intraocular pressure remained stable during the follow-up period.
Clinical Examination with in vivo Scanning Confocal
Microscopy
Using an in vivo scanning confocal microscope, there was no
obvious scar formation, neovascularization or inflammatory cell
infiltration present in the ,1.0 year group or the control group.
However, in the .1.0 year group (disease duration of 3–4 years),
thereweredensecornealscars,obviousneovascularization,activated
stromal cells and inflammatory cells. Dense, highly reflective, tiny
needle-shaped materials were present in the deep stroma. Cystic
corneal edema and a honeycomb structure were found in the area
containing corneal scars(Figure 1).
Histological Evaluation and Scoring of the Buttons
In the ,1.0 year group, corneal stromal fiber crosslinking was
found in the deep stroma, and no dense deep corneal stromal scars
were found. In addition, neither neovascularization nor in-
flammatory cell infiltration was found (Figure 2). In the .1.0 year
group, the epithelial and stromal pathological changes were more
extended and severe. There were dense corneal scars, neovascu-
larization and inflammatory cell infiltration in the stroma.
Anterior corneal scars and broken Bowman’s membranes were
also observed (Figures 3, 4).
The histological evaluation scores of corneal stromal scars and
the number of new vessels and inflammatory cells per high-power
field were obviously higher in the .1.0 year group than the
,1.0 year group (P=0.00, 0.00, and 0.01, respectively) (Figure 5).
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In the corneal scars of the .1.0 year group, many CTGF- and
TGF-b1-positive cells were found scattered throughout the deep
stroma (Figure 6), and the positive cells were mainly fibroblasts.
However, only a few TGF-b1- and CTGF-positive cells were
found in the corneal stroma of the ,1.0 year group, and no
positive cells were found in the control group.
Figure 1. Representative images of stromal scars and blood vessels in the corneal stroma of the more than 1.0 year group. (A) The
dense, highly reflective, tiny needle-shaped materials in the deep stroma; (B) obvious neovascularization in activated stromal cells; and (C) the region
of corneal scars showed cystic corneal edema and a honeycomb structure, and the cell nucleus was rarely observed.
doi:10.1371/journal.pone.0039201.g001
Figure 2. A patient with a 0.5-year history of pseudophakic bullous keratopathy. (A) A slit-lamp photograph of the cornea showing no
obvious scar formation; (B) in the histological sections, no obvious scars, neovascularization or inflammatory cells can be observed; (C) Masson’s
trichrome staining; and (D) Van Gieson staining. Scale bar 50 mm.
doi:10.1371/journal.pone.0039201.g002
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Previous reports of bullous keratopathy have primarily been
focused on the endothelial cell loss that constitutes the underlying
pathogenic basis of this disorder [12–13]. Recent studies have
demonstratedthatcornealsurfaceandstromalpathologicalchanges
occur inpatients withlong-termbullous keratopathy.Pseudophakic
bullous keratopathy has been reported to present an abnormal
corneal ocular surface in which superficial cell layers are exfoliated,
leavingbreachesintheprotectiveMUC16glycocalyx[14].Corneal
stromal pathological changes in patients with bullous keratopathy
havealsobeendemonstratedwithinvivolaserconfocalmicroscopy.
Highlyreflective,tinyneedle-shapedmaterialshavealsobeenfound
inthecornealstroma,andtheappearanceofthesematerialsmaybe
caused by crystalline or lipofuscin [15,16]. But the relationship
between the clinical disease duration time and the scar formation
had not be systemically studied before.
In our study, we also found highly reflective, tiny needle-shaped
materials in the corneal stroma of the .1.0 year bullous
keratopathy group with confocal microscopy. These needle-
shaped materials were not found in the ,1.0 year bullous
keratopathy group. A prolonged period may be required to form
deposits, such as the needle-shaped materials, in the corneal
stroma. We also evaluated the scars with Masson’s trichrome and
Van Gieson staining to confirm the correlation between the
severity of stromal pathological changes and the clinical duration.
The score of stromal scars, the number of vessels and in-
flammatory cells per high-power field all increased in the
.1.0 year bullous keratopathy group.
The molecular basis of long-term bullous keratopathy has been
investigated in different extracellular matrixes, such as collagen
and fibronectin, and with different cytokines, including the
transforming growth factors. Fibrillar deposits of an anti-adhesive
glycoprotein tenascin in the anterior and posterior stroma,
epithelial basement membrane, subepithelial fibrosis areas, and
posterior collagenous layer were found in bullous keratopathy
corneas [17]. These fibrotic changes may play a significant role in
the progression of bullous keratopathy. In corneas with bullous
keratopathy, significantly lower transcriptional activity of TGF-
beta3 mRNA was also found compared with normal tissues [18].
TGF-b1 had been found in human corneas with the bullous
keratopathy, and our findings were consistent with previous
studies. However, the current study was the first to find that
CTGF, as the effect molecule of TGF-b1 pathway, may play
a more directly role during the corneal scar formation, like in the
development of human bullous keratopathy. In our study, the
TGF-b1-positive cells and CTGF-positive cells were mainly found
in the scar area, and the locations of the positive cells were nearly
identical in the .1.0 year group. This result indicated that as
bullous keratopathy progresses, more inflammation-related or scar
formation-related cytokines might appear in the corneal stroma.
Recent fundamental studies have demonstrated that CTGF may
Figure 3. A patient with a 1.5-year history of pseudophakic bullous keratopathy. (A) A slit-lamp photograph of the cornea showing a mild
scar and neovascularization; (B) in the histological sections, scars, neovascularization and inflammatory cells can be observed; (C) Masson’s trichrome
staining; and (D) Van Gieson staining. Scale bar 50 mm.
doi:10.1371/journal.pone.0039201.g003
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clinical studies provide a direct clinical samples based proof, and
may help to pave a bridge to apply the CTGF target from bench
to bedside. There may be a way to use this information to reduce
or prevent permanent corneal scarring/fibrosis in the future.
Endothelial keratoplasty has been an alternative to penetrating
keratoplasty for the treatment of bullous keratopathy [22–26]. To
treat a stromal superficial scar of pannus, Yang et al [27] used
superficial keratectomy as an initial surgical stage in performing
successful endothelial keratoplasty in a severe bullous keratopathy
patient and achieved a good visual outcome. This patient mainly
had a superficial scar of pannus immediately anterior to Bowman’s
membrane, which allowed for superficial keratectomy as an initial
surgical procedure for the complete removal of the irregular
Figure 4. A patient with a 3-year history of pseudophakic bullous keratopathy. (A) A slit-lamp photograph of the cornea showing dense
scarring and neovascularization; (B) in the histological sections, obvious intense scarring, neovascularization and inflammatory cells can be observed;
(C) Masson’s trichrome staining; and (D) Van Gieson staining. Scale bar 50 mm.
doi:10.1371/journal.pone.0039201.g004
Figure 5. Evaluation of morphological changes in patients with bullous keratopathy. Significant differences were found between the
more than 1.0 year group and the less than 1.0 year group (*, P,0.05), including (A) corneal stromal scar grading, (B) the number of new vessels per
high-power field, and (C) the number of inflammatory cells per high-power field.
doi:10.1371/journal.pone.0039201.g005
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had mild deep stromal scarring.
In our series, all of the patients in the .1.0 year group acquired
a good visual outcome after penetrating keratoplasty. This result
indicated that penetrating keratoplasty was a good choice for long-
term bullous keratopathy. For mild stromal scarring, a 2-stage
procedure can be used to broaden the indication for endothelial
keratoplasty. However, our study was only a histological study with
limitedcornealbuttonsamples.Furtherinvestigationsareneededto
helpdeterminestromalscarchangesandthemolecularmechanism.
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